The EC has approved the extension of Stallergenes Greer’s Palforzia for the treatment of peanut allergy in toddlers.

Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...

Repurposed Drug use for cancer is exploding around the world. And today, New Year’s Day 2025, even Artificial Intelligence is ...

Maintaining optimal eye health has become more crucial in today’s fast-paced world. With the rise of digital screens and ...

We looked at data released by the Food and Drug Administration in 2013 on the ... When we shared our results with the FDA and asked for comment, the agency reiterated its recommendation that ...